Abstract
Aim:
To determine whether the cysteinyl leukotriene receptor 1 (CysLT1 receptor) modulates brain cryoinjury and whether the CysLT1 receptor antagonist pranlukast exerts a time-dependent protective effect on cryoinjury in mice.
Methods:
Brain cryoinjury was induced by applying a liquid nitrogen-cooled metal probe to the surface of the skull for 30 s. Brain lesion, neuron density, and endogenous IgG exudation were observed 24 h after cryoinjury. Transcription and the expresion of the CysLT1 receptor were detected by RT-PCR and immunoblotting, and the localization of the receptor protein by double immunofluorescence.
Results:
The mRNA and protein expressions of the CysLT1 receptor were upregulated in the brain 6-24 h after cryoinjury, and the CysLT1 receptor protein was primarily localized in the neurons, not in the neurons, not in the astrocytes or microglia. Pre-injury treatments with multi-doses and a single dose of pranlukast (0.1 mg/kg) attenuated cryoinjury, postinjury single dose (0.1 mg/kg) at 30 min (not 1 h) after cryoinjury was also effective.
Conclusion:
The CysLT1 receptor modulates cryoinjury in mice at least partly, and postinjury treatment with its antagonist pranlukast exerts the protective effect with a therapeutic window of 30 min.
Similar content being viewed by others
Article PDF
References
Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes, FASEB J 2004; 18: 842–4.
Rao AM, Hatcher JF, Kindy MS, Dempsey RJ . Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res 1999; 24: 1225–32.
Dhillon HS, Dose JM, Prasad MR . Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats. J Neurotrauma 1996; 13: 781–9.
Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 2003; 55: 195–227.
Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, et al. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose and time- dependently protects against focal cerebral ischemia in mice. Pharmacology 2005; 73: 31–40.
Zeng LH, Zhang WP, Wang RD, Wang PL, Wei EQ . Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice. Yao Xue Xue Bao 2001; 36: 148–50. Chinese.
Zhang WP, Wei EQ, Mei RH, Zhu CY, Zaho MH . Neuroprotective effect of ONO-1078, a leukotrien receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002; 23: 871–7.
Zhang LH, Wei EQ . Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats. Acta Pharmacol Sin 2003; 24: 1241–7.
Ding Q, Weit EQ, Zhang YJ, Zhang WP, Chen Z . Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in mice. Acta Pharmacol Sin 2006; 27: 1526–36.
Zhang YJ, Zhang L, Ye YL, Fang SH, Zhou Y, Zhang WP, et al. Cysteinyl leukotriene receptors CysLT1 and CusLT2 are involved in actue neuronal injury after focal cerebral ischemia in mice. Acta Pharmacol Sin 2006; 27: 1553–60.
Fang SH, Weit EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience 2006; 140: 969–79.
Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, et al. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 2004; 363: 247–51.
Kawai N, Kawanishi M, Nagao S . Treatment of cryoinjury induced brain edema with a nonspecific matrix metalloproteninase inhibitor MMI270 in rats. Acta Neurochir Suppl 2003; 86: 291–5.
Murakami K, Kondo T, Yang G, Chen SF, Morita-Fujimura Y, Chan PH . Cryoinjury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog Neurobiol 1999; 57: 286–99.
Knerlich F, Schilling L, Gorlach C, Wahl M, Ehrenreich H, Siren AL . Temporal profile of expression and cellular localization of inducible nitric oxide synthase, interleukin-1 beta and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex. Brain Res Mol Brain Res 1999; 68: 73–87.
Maeda M, Ampo K, Kiryu-Seo S, Konishi H, Ohba N, Kadono C, et al. The p53-independent nuclear translocation of cyclin G1 in degenerating neurons by ischemic and traumatic insults. Exp Neurol 2005; 193: 350–60.
Flentjar NJ, Crack PJ, Boyd R, Malin M, de Haan JB, Hertzog P, et al. Mice lacking glutathione peroxidase-1 activity show increased TUNEL staining and an accelerated inflammatory response in brain following a cold-induced injury. Exp Neurol 2002; 177: 9–20.
Sewell DL, Nacewicz B, Liu F, Macvilay S, Erdei A, Lambris JD, et al. Complement C3 and C5 play critical roles in traumatic brian cryoinjury: blicking effects on neutrophil extravasation by C5a receptor antagonist. J Neuroimmunol 2004; 155: 55–63.
Shin T, Ahn M, Kim H, Moon C, Kang TY Lee JM, et al. Temporal expression of osteopontin and CD44 in rat brains with experimental cryolesions. Brain Res 2005; 1041: 95–101.
Methia N, Andre P, Hafezi-Moghandam A, Economopoulos M, Thomas KL, Wager DD . ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med 2001; 7: 810–5.
Nag S, Papneja T, Venugopalan R, Stewart DJ . Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown Lab Invest 2005; 85: 1189–98.
Qian XD, Wei EQ, Zhang L, Sheng WW, Zhang WP, Wang ML, et al. Pranlukast a cysteinyl leukotriene receptor-1 antagonist, protects mice against brain cold injury. Eur J Pharmacol 2006; 546: 35–40.
Bramlett HM, Dietrich WD . Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 2004; 24: 133–50.
Blum D, Chtarto A, Tenebaum L, Brotchi J, Levivier M . Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis 2004; 17: 359–66.
Yrhanheikki, J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J . A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999; 96: 13 496–500.
Sanchez Mejia RO, Ona VO, Li M, Friedlander RM . Minocline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001; 48: 1393–401.
Schmidt-Kastner R, Meller D, Bellander BM, Stromberg I, Olson L, Ingvar M . A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry. J Neurosci Methods 1993; 46: 121–32.
Ogasawara H, Ishii S, Yokomizo T, Kakinuma T, Komine M, Tamaki K et al. Charcterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differntial pharmacological properties and tissue distribution. J Biol Chem 2002; 277: 18 763–8.
Saito N, Chang C, Kawai K, Joo F, Nowak TS Jr, Mies G, et al. Role of neuroexcitation in development of blood-brain barrier and oedematous changes following cerebral ischaemia and traumatic brain injury. Acta Neurochir Suppl (Wien) 1990; 51: 186–8.
Gorgulu A, Kiris T, Unal F, Turkoglu U, Kucuk M, Cobanoglu S . Protective effect of the N-methyl-D-aspartate receptor antagonists, MK-801 and CPP on cold-induced brain oedema. Acta Neurochir (Wien) 1999; 141: 93–8.
Lee JM, Grabb MC, Zipfel GJ, Choi DW . Brain tissue responses to ischemia. J Clin Invest 2000; 106: 23–31.
Yrjanheikki J, Keinanen R, Pellikka M, Hokfetl T, Koistinaho J . Tetracyclines inhibit microglial activation and are neuro-protective in global brain ischemia. Proc Natl Acad Sci USA 1998; 95: 15769–74.
Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S . Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000; 6: 797–801.
Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, et al Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002; 417: 74–8.
Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z . Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 2004; 15: 2181–4.
Song Y, Wei EQ, Zhang WP, Ge QF, Liu JR, Wang ML, et al. Minocycline inhibits NMDA-induced 5-lipoxygenase activation and cell injury in PC12 cells. Brain Res 2006; 1085: 57–67.
Tikka TM, Koistinaho JE . Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001; 166: 7527–33.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30672449).
Rights and permissions
About this article
Cite this article
Ding, Q., Fang, Sh., Zhou, Y. et al. Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice. Acta Pharmacol Sin 28, 945–952 (2007). https://doi.org/10.1111/j.1745-7254.2007.00576.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00576.x
Keywords
This article is cited by
-
Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
Psychopharmacology (2016)
-
Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist Protects Against Hippocampal Injury Induced by Transient Global Cerebral Ischemia and Reperfusion in Rats
Neurochemical Research (2015)